Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
about
Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injuryGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureAssessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumEpigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapyDifferential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.The interaction of gut microbes with host ABC transporters.Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients.Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.TLR signaling modulates side effects of anticancer therapy in the small intestine.Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria.Decreased functional activity of multidrug resistance protein in primary colorectal cancerThe human P-glycoprotein transporter enhances the type I interferon response to Listeria monocytogenes infectionSuppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer CellsPredictors of aggressive inflammatory bowel disease.Pharmacogenetics and inflammatory bowel disease: progress and prospects.Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cellsIncreased gut permeability in Crohn's disease: is TNF the link?Clinical implications of inflammatory bowel disease genetics on phenotype.Transporters and their impact on drug disposition.Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyMultidrug resistance (MDR1) gene in inflammatory bowel disease: a key player?Determination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis.What is the origin of ulcerative colitis? Still more questions than answers.Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in miceP-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.Glyceollin transport, metabolism, and effects on p-glycoprotein function in Caco-2 cellsIs there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?Pathogenesis of primary sclerosing cholangitis.The network of P-glycoprotein and microRNAs interactions.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks.Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine.
P2860
Q24629732-34FEAF09-BB65-4C4F-9117-2C8E22B1BEB3Q26852514-1A8C0F6C-4E17-46CE-8DBD-4F23FC4CC423Q28262150-976A6511-A312-4A6C-ADC8-3EAE5D344ED3Q33357010-063A13C1-8645-42D5-B88C-C224E7F26111Q33921440-6A3F3C20-D92D-4F26-BC60-3EF09536B122Q34084892-3B20FA61-EA36-4E21-A19F-6E7533D3AA25Q34503647-BAFC08CB-1E42-47A4-8B36-AA19DBF76DDCQ34538009-E4D028E0-CFFF-4EE5-B204-98A07A44B9D6Q34640725-8DB6424C-C716-4DC1-8D7F-1C3466A039A1Q35021482-42F7BFFE-3F2D-42DC-B593-C11A33A7AC41Q35047787-11F1FF8E-2E1C-455D-87BA-50B800E4D2E2Q35057014-0C289E00-2547-49ED-9D41-D7BDBF11E361Q35083876-DC3D25F6-4455-433E-9BD7-C16505A6DD88Q35114570-9EE3004D-9C4F-40E8-B938-C054833E08E9Q35550764-22B0754A-1D28-4155-AA4C-C459FE21A845Q35556544-C418CB2D-EDF3-4571-8040-D6336AD43741Q35609414-6170905A-FDE4-4CE7-8FB4-41083F81074DQ35670917-831CFF56-767C-4B7A-B704-8AF680D77B7DQ35691407-6A74D705-9E6D-4179-9835-3D31B6364EAFQ35787609-F91C310B-6993-4BD6-AE78-50BB6FD8E728Q35892881-06256B66-997D-4CDA-B836-A321F1C95F57Q35948456-B77F2BD6-D716-409C-99B3-B2F5FD3E0805Q36021426-768E4DCC-397E-497F-927E-FB647AB7B6ACQ36123304-CE610FD5-1E34-444E-B232-7B00FD9D1A03Q36209737-3CFF31C6-4BC9-4DB8-BEC6-2CF1981A4E15Q36245600-EAED62D0-3B15-4C1A-A8D1-D6A9AA866950Q36292830-0BCCEFF2-6700-499D-8CBB-201AC42935D9Q36306906-5EFA8DC4-3EEC-456A-9B92-06F620015F8EQ36636016-07145D84-48A0-45F1-9839-9079FB45C011Q36699729-BD35D177-5205-4AF3-A4F7-666E50A3762EQ36964887-BF4503E3-8CA9-4E8E-B20D-78FE0DE141E7Q37196030-34895CCB-3C71-4397-8876-7D32C4D9BCD0Q37540633-F63721EA-EC43-4FC3-844F-EDA4E6927FD9Q37712646-F402D154-6891-4667-BB57-62EA2E023372Q37925681-5D33AF65-F7A9-4407-A6C7-1E7E71C8CF3DQ37960966-6DEEAC53-8BCA-4655-BFFD-ECF0A431045FQ38152293-2939F784-2303-4F18-8F3D-A9A924629360Q38202698-99D0BAF7-AD1D-4E45-81A3-F473D8056C8BQ38339659-DB55FB8D-E972-45A8-9263-3EFFC41666D1Q39038636-EF804F54-9A51-4260-A80F-AD228F268B85
P2860
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@ast
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@en
Multidrug resistance 1 gene
@nl
type
label
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@ast
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@en
Multidrug resistance 1 gene
@nl
prefLabel
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@ast
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@en
Multidrug resistance 1 gene
@nl
P2860
P356
P1433
P1476
Multidrug resistance 1 gene (P ...... t in gastrointestinal disease?
@en
P2093
F M Moodie
J Satsangi
P2860
P304
P356
10.1136/GUT.52.5.759
P407
P50
P577
2003-05-01T00:00:00Z